Is 177lu-Prostate-Specific Membrane Antigen Radioligand Therapy Better Than Third-Line Systemic Treatment For Advanced Prostate Cancer?

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS(2017)

引用 0|浏览9
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要